Professional Documents
Culture Documents
Viral Hepatitis (Virus Hepatitis)
Viral Hepatitis (Virus Hepatitis)
Liver
Liver Diseases
Classified as
Hepatocellular
(Viral hep, Alcoholic Hepatitis)
Cholestatic
(Obstructive)- Gall stone diseases, malig
obstruction, Billiary cirrhosis)
Mixed
Clinical Manifestations
Fatigue- most characterisitic
and most common symptom.
Typically arises after activity or
exercise
Nausea, vomitings
Right upper quadrant discomfort
Itching can be there in later
stages
Clinical Manifestations
Jaundice- hall mark of Liver
disease
Usually reported darkening of
urine by the patients.
Color of stool golden yellow
Jaundice clinically detectable
at bilirubin level of 2.5 mg/dl
and above.
Clinical history
Food habits
Sexual activeness
Drug history
Blood transfusions
Alcohol intake
Physical Examination
Icterus
Hepatomegaly with tenderness
Palmar erythema
Itching marks
Fetor hepaticus (Later stages)
Ascites, edema, hepatic failure
(in fulminant hepatitis)
Jaundice
Caput medusae
Gynaecomastia
Spider Naevus/Angioma
Investigations done
Serum enzymes
Aminotransferases represent
hepatocellular injury
AST (Aspartate aminotrasferase),
usually present in liver cardiac
muscle, skeltal muscle, kidneys,
brain, pancreas, lungs, leucocytes
ALT (Alanine transferase), manly in
liver
Investigations done
In acute Hepatitis, ALT higher than
AST ratio >2:1
In alcoholic hepatitis ratio >3:1
Alkaline phosphotase, Glutamyl
transpeptidase, 5 nuclitidase
raised in cholestatic jaundice
Ultrasonography
Urine bile salts and pigments
Coagulation profile
Viral Hepatitis A
RNA virus
Most common cause of Hepatitis
worldwide
30% of viral hepatitis caused by
HAV in US
Faeco-oral route of transmission
Large outbreaks due to
contamination of food and water.
Viral Hepatitis A
Incubation period- 1to 4 weeks.
Diagnosis by anti HAV antibodies.
May be silent (subclinical) Starts by
mild fever, fatigue and few loose
stools
All cases resolve in 4-6 weeks
No chronic hepatitis or cirrhosis
seen
Treatment- supportive
Viral Hepatitis B
DNA virus
Incubation period- 30-180 days.
Blood Transmission Blood tansfusion,
syringes, drug abusers;Vertical, Sexual,
Body secretions
About 300-350 million chronic carriers
worldwide. 75% of all cases occur in Asia.
An estimated 40 million carriers are in
India, Incidence -3-4%
Diagnosis of HBV
History- Blood transmission
Viral markers
Acute IgM anti-HBc, HBeAg.
HBsAg, HBV DNA
Chronic- IgG antiHBc, HBeAg, anti
HBe, HBsag, HBV DNA
Treatment of HBV
Interferons
Lamivudine
Adefovir
Entecavir
Telbivudine
Liver transplantation
Hepatitis C Virus
200 million carriers worldwide
Incidence In US has decreased
to 18000 cases per year
$ million infected in US with
HCV and 10,000 die each year
of HCV related chr. Liver
diseases
HCV- frequent cause of
hepatocellular carcinoma
Hepatitis C Virus
Mode of transmission
paraenteraly , vertical and sexual
Clinical features Symptoms vary
from mild to fulminant hepatic failure
Incubation period 15-150 days
15% have spontaneous resolution
and 85% go into chronic HCV.HCC
devlops in 1-2% of patients
Hepatitis C
Diagnosis by Anti HCV ab, HCV
RNA
Treatment
Interferons
Ribavarin
Liver transplantation
Hepatitis D
Small RNA virus
Presents as coinfection with
Hep. D
Diagnosis by HDV RNA or HDV
antigen
Chronicity same as hepatitis B
Mode of transmision- paraentral
Treatment Interferons
Hapatitis E
RNA virus
Most commonly seen in India
Feco-oral mode of transmission,
causes epidemics
No chronic infection with Hep. E
No prophylaxis known
Treatment is supportive.
High fatality in pregnant women.
Thanks